EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Size Increment During Surveillance in Papillary Thyroid Cancer: Evidence Synthesis and Dose–Response Meta‐Analysis

Mohamed Badie Ahmed iD, Emad Naem, Harman Saman, Abeer Alsherawi, Asma Syed, Noora Al-Abdulla, Latifa Alkaabi, Mahmoud A Zirie, Suhail A Doi

Cancer Reports · 2025

DOI: 10.1002/cnr2.70183 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cancer Reports, 2025. Verfasst von Mohamed Badie Ahmed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Thyroid Neoplasms, Watchful Waiting. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Library.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Differentiated thyroid cancer has become a prevalent malignant tumor, particularly papillary thyroid carcinoma (PTC), constituting over 90% of cases. Most PTC lesions are asymptomatic and remain subclinical throughout life, and active surveillance is now being used to monitor the progression of these lesions and intervene when appropriate. This evidence synthesis aims to assess PTC progression in size over time during active surveillance in terms of PTC tumor size progression to or beyond 3 mm during the surveillance period.

Methods

A dose–response meta‐analysis was conducted using the robust error meta‐regression method, using time as the “dose” and cumulative progression (%) was assessed. A comprehensive literature review was done using PubMed/MEDLINE and EMBASE from inception till August 2024.

Results

A total of 21 studies from 7 different countries, including 14 648 participants, were included. Incident progression at 2 years of follow‐up was 1%, and this increased linearly to 12% at 20 years of follow‐up.

Conclusion

It was concluded that progression over the threshold increases linearly over time at approximately less than 1% per year. Therefore, size progression beyond the threshold occurs in a minority and in less than one eighth of subjects by two decades of follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryThyroid NeoplasmsWatchful WaitingHumansDisease ProgressionTumor Burden

Stichwörter der Autor:innen

active surveillancedose–response meta‐analysispapillary thyroid cancertumor progression

Autor:innen und Institutionen

  • Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.
  • Department of Plastic Surgery, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Endocrinology Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Department of Medicine, Hazm Mebaireek Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Kent Oncology Center, Kent, UK.

ORCID-Profile: Mohamed Badie Ahmed

Förderung

  • Qatar National Library

Zitieren

APA

Ahmed, M. B., Naem, E., Saman, H., Alsherawi, A., Syed, A., Al-Abdulla, N., Alkaabi, L., Zirie, M. A., & Doi, S. A. (2025). Size Increment During Surveillance in Papillary Thyroid Cancer: Evidence Synthesis and Dose–Response Meta‐Analysis. Cancer Reports. https://doi.org/10.1002/cnr2.70183

Vancouver

Ahmed MB, Naem E, Saman H, Alsherawi A, Syed A, Al-Abdulla N, et al. Size Increment During Surveillance in Papillary Thyroid Cancer: Evidence Synthesis and Dose–Response Meta‐Analysis. Cancer Reports. 2025. doi:10.1002/cnr2.70183

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Mohamed Badie and Naem, Emad and Saman, Harman and Alsherawi, Abeer and Syed, Asma and Al-Abdulla, Noora and Alkaabi, Latifa and Zirie, Mahmoud A and Doi, Suhail A},
  title = {Size Increment During Surveillance in Papillary Thyroid Cancer: Evidence Synthesis and Dose–Response Meta‐Analysis},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70183}
}
Kostenlos starten →